Canakinumab monoclonal antibody drug molecule. Targets interleukin-1 beta and is used in the treatment of a number of auto-inflammatory diseases. Gene

---

Canakinumab monoclonal antibody drug molecule. Targets interleukin-1 beta and is used in the treatment of a number of auto-inflammatory diseases. Generic name and stylized antibody representation.

---

Size: 6478px × 2218px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: antibody, auto-inflammatory, beta, biological, biosimilar, biotech, biotechnology, canakinumab, caps, caspase, cryopyrin-, disease, drug, fever, il-1b, immunoglobulin, immunology, infusion, injection, inn, interleukin, mab, monoclonal, nomenclature, peptide, periodic, protein, rare, syndromes